Graypoint LLC Raises Holdings in Danaher Co. (NYSE:DHR)

Graypoint LLC boosted its stake in shares of Danaher Co. (NYSE:DHR) by 1.4% in the third quarter, Holdings Channel reports. The institutional investor owned 14,131 shares of the conglomerate’s stock after acquiring an additional 199 shares during the period. Graypoint LLC’s holdings in Danaher were worth $3,929,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. CarsonAllaria Wealth Management Ltd. bought a new stake in Danaher during the second quarter valued at about $25,000. nVerses Capital LLC bought a new stake in shares of Danaher in the 2nd quarter valued at about $25,000. MFA Wealth Advisors LLC purchased a new position in shares of Danaher in the 2nd quarter worth approximately $51,000. Financial Connections Group Inc. bought a new position in shares of Danaher during the 2nd quarter worth approximately $51,000. Finally, Western Pacific Wealth Management LP purchased a new stake in Danaher during the first quarter valued at approximately $55,000. Institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Leerink Partners upped their price target on Danaher from $275.00 to $280.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Raymond James reduced their target price on Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. Royal Bank of Canada lowered their price target on Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. StockNews.com upgraded shares of Danaher from a “hold” rating to a “buy” rating in a report on Wednesday. Finally, Stephens reiterated an “overweight” rating and issued a $315.00 target price on shares of Danaher in a research note on Wednesday, October 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $287.16.

Danaher Stock Performance

NYSE DHR opened at $247.81 on Thursday. Danaher Co. has a fifty-two week low of $192.35 and a fifty-two week high of $281.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The firm has a market capitalization of $178.99 billion, a P/E ratio of 47.29, a PEG ratio of 4.55 and a beta of 0.85. The stock has a 50-day simple moving average of $265.79 and a two-hundred day simple moving average of $260.75.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. Danaher’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period last year, the business earned $2.02 earnings per share. On average, equities analysts forecast that Danaher Co. will post 7.51 earnings per share for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

Insider Buying and Selling at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the sale, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at $1,130,374.44. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 10.90% of the stock is owned by corporate insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.